Prognostic Biomarkers of Salvage Chemotherapy Following Nivolumab Treatment for Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Recent studies have suggested the benefit of salvage chemotherapy (SCT) after immune checkpoint inhibitor (ICI) treatment for recurrent and metastatic head and neck squamous cell carcinoma (R/M HNSCC). We retrospectively examined the outcome of SCT and the usefulness of the serum C-reactive protein...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Wakasaki, Takahiro, Yasumatsu, Ryuji, Masuda, Muneyuki, Takeuchi, Toranoshin, Manako, Tomomi, Matsuo, Mioko, Jiromaru, Rina, Uchi, Ryutaro, Komune, Noritaka, Noda, Teppei, Nakagawa, Takashi
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2020
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7463840/
https://ncbi.nlm.nih.gov/pubmed/32824226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12082299
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky